Coronado is a biopharmaceutical company focused on novel immunotherapy agents for cancer and inflammatory diseases. Coronado鈥檚 two principal pharmaceutical product candidates are initially targeted for clinical development for inflammatory bowel disease, multiple sclerosis and acute myeloid leukemia.
Tags
cndobobby sandageceocfobioworld insightat a glance
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
